| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d40a185e47b2af2ccdab8dca479cb6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2016-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_229d82b30f511b2b002ac07cd802bab7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e85be465a156e1d48dde1b7e03f196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dff0954f556999886f3a94e26fbe52c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f2d12ce5a8d5eb1211702a4e975ef39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_549cb8660011f7a6d6683f34db157d5a |
| publicationDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016111364-A1 |
| titleOfInvention |
Method for predicting prognosis of patient with cancer or inflammatory disease |
| abstract |
Disclosed is a novel means whereby the prognosis of a patient with cancer or an inflammatory disease can be predicted. The method according to the present invention for predicting the prognosis of a patient with cancer or an inflammatory disease comprises measuring the expression amount of FROUNT gene in a specimen collected from the patient. The FROUNT gene is a bad prognosis factor. Thus, the prognosis of the patient is predicted to be better with a decrease in the expression amount of the FROUNT gene. Alternatively, the expression amount of a CC chemokine receptor/ligand gene in a specimen collected from the patient is measured. A CC chemokine receptor (for example, CCR2 or CCR5)/ligand gene is a good prognosis factor. Thus, the prognosis of the patient is predicted to be better with an increase in the expression amount of the CC chemokine receptor/ligand gene. |
| priorityDate |
2015-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |